|
Dec 15
|
Apellis (APLS) Falls on Europe Update for Pegcetacoplan in GA
|
|
Dec 14
|
Amgen's (AMGN) Tarlatamab BLA Gets FDA Priority Tag for SCLC
|
|
Dec 13
|
C4 Therapeutics (CCCC) Soars on Oncology Deal With Merck
|
|
Dec 13
|
Candel (CADL) Rises on FDA's Fast Track Status for CAN-2409
|
|
Dec 12
|
GSK's Jemperli Gets EU Nod for Endometrial Cancer Expanded Use
|
|
Dec 11
|
Pfizer's (PFE) Multiple Myeloma Drug Elrexfio Gets Nod in EU
|
|
Dec 8
|
Kymera (KYMR) Rises as Dosing Begins in AD Study on KT-474
|
|
Dec 7
|
Syros (SYRS) Rises on Upbeat Initial Study Data on Tamibarotene
|
|
Dec 1
|
AstraZeneca (AZN) to Discontinue Two Studies on Lokelma
|
|
Nov 29
|
Immunovant (IMVT) Up on Positive Initial IMVT-1402 MAD Study Data
|
|
Nov 29
|
SpringWorks (SWTX) Rises on FDA Nod for Desmoid Tumor Drug
|
|
Nov 28
|
Xenon (XENE) Up on Top-Line Data From MDD Drug Phase II Study
|
|
Nov 28
|
TC BioPharm (TCBP) Falls Despite FDA Clearing IND for AML Drug
|